Huize Holding Limited — FY2021 Form 20-F
Reporting period: Year ended December 31, 2021. Although the request references 2021 Q4, this is an annual filing; standalone fourth-quarter results are not clearly provided. Financial statements are prepared under U.S. GAAP. Amounts below are in RMB unless stated otherwise.
Business context
Huize is a China-focused online insurance intermediary. It distributes policies underwritten by insurer partners and earns brokerage commissions; it does not underwrite insurance risk. The Cayman Islands parent consolidates its China operating business through contractual arrangements with a variable interest entity (VIE), rather than direct equity ownership of the VIE.
Key financial and operating metrics
| Metric | FY2021 | FY2020 |
|---|---|---|
| Total operating revenue | RMB2,245.0 million (US$352.3 million), up 84.0% | RMB1,220.2 million |
| Brokerage income | RMB2,232.3 million | RMB1,215.4 million |
| Operating loss | RMB114.4 million (US$18.0 million) | RMB25.9 million |
| Net loss | RMB107.7 million (US$16.9 million); RMB0.11 loss per share | RMB18.3 million; RMB0.02 loss per share |
| Operating cash flow | Use of RMB175.9 million | Generation of RMB137.7 million |
| Investing cash flow | Use of RMB80.9 million | Use of RMB31.1 million |
| Financing cash flow | Generation of RMB141.9 million | Generation of RMB383.1 million, including IPO proceeds |
| Cash and cash equivalents | RMB381.2 million | RMB404.6 million |
| Restricted cash | RMB227.8 million | RMB324.3 million |
| Total assets / total liabilities | RMB1,857.5 million / RMB1,496.5 million | RMB1,336.0 million / RMB867.3 million |
| Bank borrowings | RMB236.7 million: RMB216.7 million short-term and RMB20.0 million long-term | RMB85.4 million: RMB31.5 million short-term and RMB53.9 million long-term |
| Operating lease liabilities | RMB264.1 million | RMB264.9 million |
Cost of revenue rose 107.5% to RMB1,688.1 million. Revenue less cost of revenue implies gross profit of approximately RMB557.0 million and a 24.8% margin, versus approximately RMB406.7 million and 33.3% in 2020; these are arithmetic estimates, not separately presented filing metrics. Operating expenses totaled RMB2,359.4 million, or 105.1% of revenue.
Gross written premiums (GWP) facilitated increased 66.2% to RMB5,018.2 million; first-year premiums rose 99.2% to RMB3,123.8 million. Cumulative insurance clients grew to 7.5 million and insured persons to 62.5 million.
Material changes versus prior periods
- Revenue growth accelerated, but costs and expenses grew faster: operating costs and expenses rose 89.3%, and the operating loss widened from RMB25.9 million to RMB114.4 million.
- The company moved from positive operating cash flow in 2020 to a RMB175.9 million cash outflow in 2021. Accounts receivable rose from RMB232.6 million to RMB777.3 million; accounts payable also increased sharply, from RMB227.5 million to RMB680.4 million.
- Life and health products generated 97.2% of brokerage income. The five largest insurer partners contributed 78.4% of revenue, up from 63.0% in 2020. The top five products represented 44.8% of GWP, versus 29.4% in 2020.
- Research and development expense increased 145.2% to RMB120.5 million. Selling expense increased 52.1% to RMB350.6 million, while general and administrative expense increased 31.6% to RMB197.6 million.
Outlook, risks and unusual items
- Management expects existing cash and anticipated operating cash flows to cover working capital and capital expenditures for at least 12 months. It provided no quantitative revenue, earnings or cash-flow guidance. Management identified regulatory change, customer acquisition costs, partner concentration and COVID-19 as factors that could affect performance.
- Liquidity is constrained by cash held in China, restricted premium and pledged deposits, and foreign-exchange and dividend-transfer rules. The filing states that 79.2% of cash and restricted cash was held in China and 78.0% was held by the VIE and denominated in RMB. No dividends had been paid, and none were planned for the foreseeable future.
- The business faces significant China regulatory and structural risks, including uncertainty over VIE enforceability, evolving insurance-intermediary and online-insurance rules, data privacy and cybersecurity requirements, and potential overseas-listing filings or reviews. The filing says required material operating licenses had been obtained, while noting that additional permissions might be required.
- The company disclosed historical compliance issues, including misuse of insurance-premium account funds and collection of premiums by some unlicensed partners. It reported returning misused premiums and ending those partner arrangements, but warned that retrospective regulatory action remains possible. It also discontinued past cash rewards to prospective customers over regulatory concerns.
- The auditor stated that it could not be inspected by the PCAOB at the time of filing; the filing warned of possible U.S. trading restrictions or delisting under the HFCAA. The financial statement audit opinion was unqualified, but management found disclosure controls and internal control over financial reporting ineffective due to a material weakness: insufficient personnel with appropriate U.S. GAAP and SEC reporting expertise. No auditor attestation of internal controls was included.
- Other notable items: 2021 operating cash flow was negative despite rapid revenue growth; the company acquired insurance-related licenses and businesses during the year and completed the acquisition of Shanghai Senhao in March 2022; share-based compensation was reversed by RMB1.8 million in 2021. The filing reported no material legal proceedings.
Most important facts for investors to verify
- Whether the sharp rise in accounts receivable, particularly its concentration in a small number of insurer counterparties, is collectible on schedule and can convert into operating cash.
- Whether the company can reduce customer-acquisition and channel costs enough to restore margins and profitability while complying with changing online-insurance rules.
- Current status of the disclosed material weakness, remediation progress, and PCAOB inspection and HFCAA developments affecting the auditor and ADS listing.
- Whether cash described as available for operations is accessible to the Cayman parent, given restricted deposits, VIE arrangements, and PRC remittance controls.
- Whether insurer and product concentration, bank borrowing growth, lease commitments and acquisition obligations have changed since December 31, 2021.